METTL14-mediated m6A modification in tumor-associated macrophages (TAMs) were found to modulate tumor-infiltrating CD8+ T cells, since macrophage-specific knockout of Mettl14 drives CD8+ T cell differentiation along a dysfunctional trajectory, impairing CD8+ T cells to eliminate tumors (90). The gene discussed is CD8A; the disease is neoplasm.